Hekat Fluidics develops the NanoSorter, described as the first nano-sorter of exosomes, intended to isolate early cancer biomarkers from a simple blood draw. The company claims the NanoSorter is a unique innovation worldwide and has launched its commercialisation. Hekat Fluidics is based in Pessac on the AMPeRIS business park. Financially, it has received regional subsidies from Région Nouvelle-Aquitaine and equity investment from business angels, and has just raised an additional €2.4 million. The articles do not report revenue, user counts, or a founding year.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Jul 2026